Confirmation and Quantitation of Six Opiates in Urine Using the ISQ Single Quadrupole GC-MS

Significance of the Topic

Opiates remain among the most abused and regulated analgesic compounds. Reliable confirmation and quantitation of multiple opiates in biological matrices such as urine are essential for forensic toxicology, clinical screening, and workplace testing. A streamlined, robust GC-MS method that addresses structural similarities and matrix interferences can improve laboratory throughput and data confidence.

Objectives and Study Overview

This work aimed to develop and validate a single-quadrupole GC-MS assay for simultaneous confirmation and quantitation of six opiates—codeine, morphine, hydrocodone, hydromorphone, oxycodone, and oxymorphone—in human urine. The method combines dual chemical derivatization and optimized chromatographic separation to replace multiple workflows with one reliable protocol.

Methodology

• Sample Preparation: 2 mL urine aliquots spiked with deuterated internal standards; enzymatic hydrolysis to release glucuronide-conjugates.
• Dual Derivatization: First, oxyme formation via hydroxylamine to stabilize keto groups; second, trimethylsilylation with BSTFA+1% TMCS to enhance volatility.
• Extraction: Solid-phase extraction using Verify-CX cartridges (200 mg, 10 mL) to remove matrix components.
• Calibration and QC: Single-point matrix-matched calibrator at 300 ng/mL; quality controls at 120 ng/mL and 375 ng/mL; negative controls included.
• Data Acquisition: Selected ion monitoring for three target and two qualifier ions per analyte; automated confirmation by ion ratios and retention time using ToxLab Forms software.

Instrumentation

• Thermo Scientific ISQ single quadrupole mass spectrometer
• TRACE GC Ultra gas chromatograph with split/splitless inlet
• AS 3000 II autosampler
• TraceGOLD TG-1MS analytical column (15 m × 0.25 mm × 0.25 µm)
• Thermo Scientific HyperSep Verify-CX SPE cartridges
• ToxLab Forms data processing software

Main Results and Discussion

• Separation: Dual derivatization and TG-1MS column eliminated coelution; clear baseline resolution of all six opiates.
• Linearity: 30–5000 ng/mL for five analytes, 30–1200 ng/mL for oxymorphone; correlation coefficients (R²) > 0.9960.
• Precision: Intra- and inter-batch coefficients of variation < 5% at both QC levels; batch-to-batch CVs typically < 4%.
• Sensitivity: Limit of quantitation at 30 ng/mL using 2 mL sample volume meets forensic cutoffs.

Benefits and Practical Applications

The streamlined workflow—single extraction, derivatization, and injection—reduces hands-on time and consumable costs while maintaining high accuracy and precision. It is well suited for high-throughput forensic and clinical laboratories requiring reliable multi-analyte opiate screening.

Future Trends and Potential Applications

Advances may include integration with high-resolution MS for improved selectivity, automation of hydrolysis and SPE steps, and extension of the platform to additional drug classes or metabolites. Data-management enhancements will further reduce review time and support regulatory compliance.

Conclusion

This single-quadrupole GC-MS method delivers rapid, sensitive, and precise confirmation and quantitation of six opiates in urine. Optimized derivatization and chromatographic conditions ensure robust separation and low detection limits, making it a valuable tool for forensic toxicology and clinical applications.

Reference

• Baselt R. Disposition of Toxic Drugs and Chemicals in Man, 8th Edition. Biomedical Publications; 2008.
• Ropero-Miller JD, Lambing MK, Winecker RE. Simultaneous Quantification of Opiates in Blood by GC-EI-MS Analysis Following Deproteination, Detautomerization of Keto Analytes, SPE and TMS Derivatization. J Anal Toxicol. 2002;26:524–528.